Quick Answer
InflaRx N.V. reported Research And Development Expense of $25.72 million for the year ending 2025.
- InflaRx N.V. showed a decrease of -27.3% in Research And Development Expense from 2024 to 2025.
- This data is from InflaRx N.V.'s annual report (Form 10-K), filed with the SEC on March 20, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), InflaRx N.V.'s Research And Development Expense has grown by 639.5%.
- Historical annual values: Fiscal year 2025: $25.72 million | Fiscal year 2024: $35.36 million | Fiscal year 2023: $41.02 million | Fiscal year 2022: $37.53 million | Fiscal year 2021: $35.70 million | Fiscal year 2020: $25.68 million | Fiscal year 2019: $44.58 million | Fiscal year 2018: $25.03 million | Fiscal year 2017: $14.41 million | Fiscal year 2016: $5.28 million | Fiscal year 2015: $3.48 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: